Guided Therapeutics - GTHP Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Guided Therapeutics - GTHP

GTHP 0.270

0.0%

Oct 31 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: David S. who started this subject	7/10/2001 7:49:34 PM
From: A.J. Mullen	Read Replies (1) of 118

Safeco Reports 17.6% Passive Stake In Spectrx Updated: Tuesday, July 10, 2001 03:06 PM ET Email this article to a friend! Printer-friendly version WASHINGTON (Dow Jones)--Safeco Corp. (SAFC, news, msgs) reported holding a 17.6% stake in Spectrx Inc. (SPRX, news, msgs), according to a Schedule 13G filed Tuesday with the Securities and Exchange Commission. As of June 30, Safeco beneficially owned 1.5 million Spectrx common shares. A Schedule 13G denotes a passive investment stake in a company. Filers aren't required to provide a reason for any changes in stake, and aren't required to detail any transactions. Spectrx develops painless and bloodless alternatives to diagnostic and monitoring procedures. -Todd Goren, Dow Jones Newswires; 202-628-9782 (http://www.quicken.com/investments/news/story/djbn/?story=/news/stories/dj/20010710/BT20010710004984.htm&symbol=SPRX)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next